News + Filings Transactions Holdings
|
NBVM GP, LLC
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/12/2022 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 1.1M | $4.22 | $4.5M | See footnote | 04/12/2022 |
| 04/12/2022 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 527.8k | $4.22 | $2.2M | See footnote | 04/12/2022 |
| 04/12/2022 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 765k | $4.22 | $3.2M | See footnote | 04/12/2022 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series A Preferred Stock | 643.7k | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series B Preferred Stock | 498.9k | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series B Preferred Stock | 498.9k | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series C Preferred Stock | 317.9k | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series C Preferred Stock | 317.9k | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series D Preferred Stock | 201k | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series D Preferred Stock | 86.2k | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Purchase | Common Stock | 40.6k | $24.00 | $975k | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series A Preferred Stock | 643.7k | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Common Stock | 2.4M | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Common Stock | 1.9M | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Purchase | Common Stock | 94.8k | $24.00 | $2.3M | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series E Preferred Stock | 94k | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series E Preferred Stock | 40.3k | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series F Preferred Stock | 131.8k | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series F Preferred Stock | 56.5k | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series G Preferred Stock | 477.9k | $0.00 | $0 | By: North Bridge Venture Partners 7, L.P. | 07/26/2021 |
| 07/26/2021 | Couchbase, Inc. | | Conversion | Series G Preferred Stock | 204.8k | $0.00 | $0 | By: North Bridge Venture Partners VI, L.P. | 07/26/2021 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Common Stock | 651.5k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Common Stock | 319.3k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Common Stock | 471.9k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Sale | Common Stock | 11.4k | $16.00 | $181.8k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Sale | Common Stock | 5.6k | $16.00 | $89.1k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Sale | Common Stock | 7.3k | $16.00 | $116.1k | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 117.4k | $16.00 | $1.9M | See Footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 57.6k | $16.00 | $921k | See Footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Purchase | Common Stock | 75k | $16.00 | $1.2M | See Footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/A Convertible Preferred Stock | 1.2M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/A Convertible Preferred Stock | 567.4k | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/A Convertible Preferred Stock | 1.7M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/B Convertible Preferred Stock | 1.1M | $0.00 | $0 | See footnote | 05/05/2020 |
| 05/05/2020 | Lyra Therapeutics, Inc. | LYRA | Conversion | Series A-1/B Convertible Preferred Stock | 542k | $0.00 | $0 | See footnote | 05/05/2020 |
|
|